BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
TheSchall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit againstBioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) for violations of the federal securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering (“IPO”) conducted on September 26, […]